Effect of concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) on the efficacy and safety of ixekizumab in biologic dmard-naive patients with active psoriatic arthritis

Effect of concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) on the efficacy and safety of ixekizumab in biologic dmard-naive patients with active psoriatic arthritis

Bibliographic Details
Main Authors: Coates, LC, Gottlieb, AB, Shuler, CL, Lin, C-Y, Samanta, S, Moriarty, SR, Lee, CH, Mease, PJ
Format: Conference item
Published: BMJ 2016

Similar Items